MICRO Insider

[Losingmoney]

NVAX--Insider purchased 50,000 shares at $2.04. Stock closed yesterday at $1.98. Large short position. Do your own research.

insider data provided by www.scumfish.com

Novavax, Inc. (Novavax) is a biopharmaceutical company focused on developing recombinant vaccines. The Company's technology platform is based on the virus-like particles (VLPs). The VLPs are genetically engineered three-dimensional nanostructures, which incorporate immunologically important recombinant proteins. Recombinant protein-based vaccines are used and accepted. The production technology uses insect cells rather than chicken eggs or mammalian cells. In May 209, the Company produced the first batch of non-cGMP influenza A (H1N1) VLP vaccine candidate. In October 2009, Novavax, initiated a two-stage clinical trial of the H1N1 vaccine candidate in Mexico in collaboration with Laboratorio Avi-Mex S.A. de C.V. (Avimex). The Company have also developed the vaccine candidates for both respiratory syncytial virus (RSV) and varicella zoster virus (VZV), both of which are being evaluated in pre-clinical studies.